Biogen CEO Christopher Viehbacher outlines a bold new vision at LABEST 2024, highlighting innovation in immunology, rare disease, and biotech leadership.
Share this post
A New Era for Biogen and LA Biotech…
Share this post
Biogen CEO Christopher Viehbacher outlines a bold new vision at LABEST 2024, highlighting innovation in immunology, rare disease, and biotech leadership.